Maulavizada Husna, Emmerton Lynne, Hattingh Hendrika Laetitia
School of Pharmacy, Curtin University, GPO Box U1987, Perth, WA, 6845, Australia.
BMC Health Serv Res. 2016 Apr 26;16:146. doi: 10.1186/s12913-016-1406-6.
The pressure on healthcare services worldwide has driven the incorporation of disease state management services within community pharmacies in developed countries. Pharmacists are recognised as the most accessible healthcare professionals, and the incorporation of these services facilitates patient care. In Australia, the opportunity to manage pharmacy patients with mental illness has been underutilised, despite the existence of service models for other chronic conditions. This paper is an independent evaluation of a novel service developed by a community pharmacy in Perth, Western Australia. The service represents collaboration between a nurse practitioner and community pharmacy staff in the management of mental health patients with metabolic risks.
We applied practice service standards for Australian community pharmacies to develop an evaluation framework for this novel service. This was followed by semi-structured interviews with staff members at the study pharmacy to explore service processes and procedures. Descriptive analysis of interviews was supplemented with analysis of patients' biometric data. All data were evaluated against the developed framework.
The evaluation framework comprised 13 process, 5 outcomes, and 11 quality indicators. Interview data from eight staff members and biometric data from 20 community-dwelling mental health patients taking antipsychotics were evaluated against the framework. Predominantly, patients were managed by the pharmacy's nurse practitioner, with medication management provided by pharmacists. Patients' biometric measurements comprised weight, blood pressure, blood glucose levels, lipid profiles and management of obesity, smoking, hypertension and diabetes. Positive outcomes observed in the patient data included weight loss, smoking cessation, and improved blood pressure, blood glucose and lipid levels.
The developed framework allowed effective evaluation of the service, and may be applicable to other pharmacy services. The metabolic clinic met key process, quality and outcomes indicators. The positive patient outcomes may assist in securing further funding.
全球医疗服务面临的压力促使发达国家将疾病状态管理服务纳入社区药房。药剂师被认为是最容易接触到的医疗保健专业人员,这些服务的纳入有助于患者护理。在澳大利亚,尽管存在针对其他慢性病的服务模式,但管理患有精神疾病的药房患者的机会尚未得到充分利用。本文是对西澳大利亚州珀斯一家社区药房开发的一项新型服务的独立评估。该服务代表了一名执业护士与社区药房工作人员在管理患有代谢风险的精神健康患者方面的合作。
我们应用澳大利亚社区药房的实践服务标准来制定这项新型服务的评估框架。随后,对研究药房的工作人员进行了半结构化访谈,以探讨服务流程和程序。对访谈的描述性分析辅以患者生物特征数据的分析。所有数据均根据制定的框架进行评估。
评估框架包括13个流程、5个结果和11个质量指标。根据该框架对来自8名工作人员的访谈数据和20名服用抗精神病药物的社区精神健康患者的生物特征数据进行了评估。主要由药房的执业护士管理患者,药剂师提供药物管理。患者的生物特征测量包括体重、血压、血糖水平、血脂谱以及肥胖、吸烟、高血压和糖尿病的管理。在患者数据中观察到的积极结果包括体重减轻、戒烟以及血压、血糖和血脂水平的改善。
制定的框架能够对该服务进行有效评估,并且可能适用于其他药房服务。代谢诊所符合关键流程、质量和结果指标。患者的积极结果可能有助于获得更多资金。